Linked Data API

Show Search Form

Search Results

650311
registered interest false more like this
date less than 2016-12-02more like thismore than 2016-12-02
answering body
Department for International Development more like this
answering dept id 20 remove filter
answering dept short name International Development more like this
answering dept sort name International Development more like this
hansard heading Drugs: Manufacturing Industries remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for International Development, whether it is her Department's policy to implement the recommendation in the report by the UN High Panel of Access to Medicines, Promoting innovation and access to health technologies, published in September 2016, on improving standards of transparency in the pharmaceutical industry. more like this
tabling member constituency Belfast South more like this
tabling member printed
Dr Alasdair McDonnell more like this
uin 55953 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2016-12-07more like thismore than 2016-12-07
answer text <p>While we support the aims of the UN High Level Panel on Access to Medicines, we note that this panel of experts could not reach consensus. DFID supports improving transparency in the pharmaceutical industry and funds the Access to Medicine Index to increase the transparency of pharmaceutical companies.</p><p> </p> more like this
answering member constituency Stockton South more like this
answering member printed James Wharton remove filter
question first answered
less than 2016-12-07T17:28:35.39Zmore like thismore than 2016-12-07T17:28:35.39Z
answering member
4123
label Biography information for Lord Wharton of Yarm more like this
tabling member
1596
label Biography information for Dr Alasdair McDonnell more like this